Skip to main content
Global Cord Blood Corp (CORBF)
OTCMKTS: CORBF · Delayed Price · USD
1.200
+0.080 (7.14%)
May 31, 2024, 4:00 PM EDT - Market closed

Global Cord Blood Revenue

In the fiscal year ending March 31, 2022, Global Cord Blood had annual revenue of $194.26M with 10.06% growth. Revenue in the quarter ending March 31, 2022 was $46.44M with 0.92% year-over-year growth.

Revenue (ttm)
$194.26M
Revenue Growth
+10.06%
P/S Ratio
0.83
Revenue / Employee
$161,613
Employees
1,202
Market Cap
160.70M USD

Revenue Chart

* The company reports in CNY currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 2022194.26M17.75M10.06%
Mar 31, 2021176.51M2.01M1.15%
Mar 31, 2020174.49M27.22M18.48%
Mar 31, 2019147.28M-934.34K-0.63%
Mar 31, 2018148.21M37.93M34.39%
Mar 31, 2017110.28M7.76M7.56%
Mar 31, 2016102.53M-51.93K-0.05%
Mar 31, 2015102.58M10.22M11.06%
Mar 31, 201492.36M7.84M9.27%
Mar 31, 201384.52M24.13M39.97%
Mar 31, 201260.39M8.54M16.47%
Mar 31, 201151.85M13.54M35.33%
Mar 31, 201038.31M9.84M34.58%
Mar 31, 200928.47M-4.77M-14.35%
Mar 31, 200833.24M31.59M1,919.66%
Mar 31, 20071.65M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings

CORBF News

More News